Trial
NCT01652261
Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
Polish Lymphoma Research Group
Condition
Hodgkin Lymphoma
Intervention
ABVD + FDG-PET/CT Scan treatment adaptation
Why stopped
Study closed due to lack of recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-15